GENERAL ORTHOPAEDICS
Hyaluronic acid more clinically effective compared to betamethasone for knee OA
This report has been verified
by one or more authors of the
original publication.
Open Access Rheumatology: Research and Reviews 2015:7 9–18
200 patients with knee osteoarthritis were randomized to an intra-articular injection protocol of either hyaluronic acid (HA) or betamethasone (BM), and followed up for a year. The purpose of this study was to compare clinical outcome measures between HA and BM injections. With the exception of global pain assessment at 3 months, which demonstrated significantly lower pain in the BM group compared to HA group, all differences in outcome measures favoured the HA group compared to the BM group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
